Goodwin Procter partner Rob Cerwinski will be a panelist for the session, "Declining to Dance? Lessons Learned from Early BPCIA Cases on Whether the Pathway is Mandatory." The speakers will review biosimilars litigation to date, analyze the arguments and outcomes of each case and review the open questions not reached by the Court.
Speaking Engagements June 01, 2015 - June 03, 2015
New York, NY